Heart rhythm · 2026
Zero-fluoroscopy approach to left atrial appendage closure using intracardiac echo guidance.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hoskins Michael H, Bestawros Michael, Nair Sandeep, Adjei-Poku Yaw, Remo Benjamin, Mazer Sean
Аннотация
BACKGROUND: Left atrial appendage closure (LAAC) with the Watchman™ device is typically performed with the use of transesophageal echocardiography (TEE) and fluoroscopy. LAAC guided by intracardiac echo (ICE) without the use of fluoroscopy has not been previously described.
OBJECTIVE: In this series, we describe the safety and feasibility of Watchman™ implantation using only ICE imaging and without the use of fluoroscopy.
METHODS: 214 patients undergoing LAAC with the Watchman FLX™ or Watchman FLX™ Pro device and using a planned fluoroscopy-free approach were studied. ICE was used for echocardiographic imaging in all cases. TEE was not used in any cases. Fluoroscopy was used as a bail-out approach when it was felt to be clinically necessary by the operator. Peri-procedural, 45-day, and 1-year efficacy and safety outcomes were assessed.
RESULTS: In 203/214 patients (94.8%), LAAC was completed without the use of fluoroscopy. Bail-out fluoroscopy was required in 11/214 patients (5.1%). Successful device implantation was completed in 212/214 patients (99.1%). The rate of any peri-device leak at 45 days post-procedure was 11.6%. Procedural complications were limited to one pericardial effusion and one case of ventricular tachycardia.
CONCLUSION: LAAC with the Watchman™ device using ICE imaging and without the use of fluoroscopy appears to be safe and effective. The rates of procedural success, complications, and peri-device leaks on 45 day follow up were consistent with that seen in pivotal clinical trials. Further studies are needed to assess the broader applicability of this technique.
OBJECTIVE: In this series, we describe the safety and feasibility of Watchman™ implantation using only ICE imaging and without the use of fluoroscopy.
METHODS: 214 patients undergoing LAAC with the Watchman FLX™ or Watchman FLX™ Pro device and using a planned fluoroscopy-free approach were studied. ICE was used for echocardiographic imaging in all cases. TEE was not used in any cases. Fluoroscopy was used as a bail-out approach when it was felt to be clinically necessary by the operator. Peri-procedural, 45-day, and 1-year efficacy and safety outcomes were assessed.
RESULTS: In 203/214 patients (94.8%), LAAC was completed without the use of fluoroscopy. Bail-out fluoroscopy was required in 11/214 patients (5.1%). Successful device implantation was completed in 212/214 patients (99.1%). The rate of any peri-device leak at 45 days post-procedure was 11.6%. Procedural complications were limited to one pericardial effusion and one case of ventricular tachycardia.
CONCLUSION: LAAC with the Watchman™ device using ICE imaging and without the use of fluoroscopy appears to be safe and effective. The rates of procedural success, complications, and peri-device leaks on 45 day follow up were consistent with that seen in pivotal clinical trials. Further studies are needed to assess the broader applicability of this technique.